Prognostic factors for corneal graft recovery after severe corneal graft rejection following penetrating keratoplasty

详细信息    查看全文

• 作者：Katsuya Yamazoe (1) (2)
  Kyoko Yamazoe (1)
  Seika Shimazaki-Den (1)
  Jun Shimazaki (1) (2)
  
• 关键词：Penetrating keratoplasty ; Rejection ; Systemic steroid ; Risk factor ; Success rate
• 刊名：BMC Ophthalmology
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：13
• 期：1
• 全文大小：146KB
• 参考文献：1. Wilson SE, Kaufman HE: Graft failure after penetrating keratoplasty. / Surv Ophthalmol 1990, 34:325-56. CrossRef
  2. Vail A, Gore SM, Bradley BA, Eastly DL, Rogers CA: Corneal graft survival and visual outcome. A multicenter study. Corneal Transplant Follow-up Study Collaborators. / Ophthalmology 1994, 101:120-27.
  3. Inoue K, Amano S, Oshika T, Tsuru T: Risk factors for corneal graft failure and rejection in penetrating keratoplasty. / Acta Ophthalmol Scand 2001, 79:251-55. CrossRef
  4. Epstein AJ, De Castro TN, Laibson PR, Cohen EJ, Rapuano CJ: Risk factors for the first episode of corneal graft rejection in keratoconus. / Cornea 2006, 25:1005-011. CrossRef
  5. Bachmann B, Taylor RS, Cursiefen C: Corneal neovascularisation as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. / Ophthalmology 2010, 117:1300-305. CrossRef
  6. Perera C, Jhanji V, Vajpayee RB: Factors influencing outcome of the treatment of allograft corneal rejection. / Am J Ophthalmol 2011, 152:358-63.
  7. Naacke HG, Borderie VM, Bourcier T, Touzeau O, Moldovan M, Laroche L: Outcome of corneal transplantation rejection. / Cornea 2001, 20:350-53. CrossRef
  8. Sangwan VS, Ramamurthy B, Shah U, Garg P, Sridhar MS, Rao GN: Outcome of corneal transplant rejection: a 10-year study. / Clin Exp Ophthalmol 2005, 33:623-27. CrossRef
  9. Wagoner MD, Ba-Abbad R, Sutphin JE, Zimmerman MB: Corneal transplant survival after onset of severe endothelial rejection. / Ophthalmology 2007, 114:1630-636. CrossRef
  10. Hill JC, Maske R, Watson P: Corticosteroids in corneal graft rejection. Oral versus single pulse therapy. / Ophthalmology 1991, 98:329-33.
  11. Musch DC, Schwartz AE, Fitzgerald-Shelton K, Sugar A, Meyer RF: The effect of allograft rejection after penetrating keratoplasty on central endothelial cell density. / Am J Ophthalmol 1991, 111:739-42.
  12. Shimazaki J, Iseda A, Satake Y, Shimazaki-Den S: Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty. A prospective, randomized, clinical trial. / Ophthalmology 2012, 119:668-73. CrossRef
  13. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2415/13/5/prepub
  
• 作者单位：Katsuya Yamazoe (1) (2)
  Kyoko Yamazoe (1)
  Seika Shimazaki-Den (1)
  Jun Shimazaki (1) (2)
  
  1. Department of Ophthalmology, Tokyo Dental College, 5-11-13 Sugano, Ichikawa, Chiba, 272-8513, Japan
  2. Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan
  

文摘

Background To investigate the outcome and prognostic factors for corneal graft recovery after severe corneal graft rejection following penetrating keratoplasty (PKP) treated with topical and systemic steroids. Methods Fifty-eight eyes in 58 patients with severe corneal graft rejection following PKP were treated with topical and systemic steroids. Factors affecting the reversibility and maintenance of graft transparency were analyzed. Results Graft transparency was restored in 37 of 58 eyes (63.8%). Clarity of the graft was maintained in 25 of 37 eyes after transparency was restored, while corneal decompensation developed at a mean of 6.0?±-.3 months in the remainder. The interval between rejection and treatment with systemic steroids was shorter in cases that recovered graft transparency (OR, 0.88, 95% CI. 0.80-.97, P--.0093). Corneal decompensation after the recovery of corneal transparency tend to occur in cases of regraft (OR, 0.09, 95% CI. 0.01-.54, P--.0091). Conclusions Severe corneal graft rejection after PKP was reversible in approximately two-thirds of the cases, with graft transparency being maintained in two-thirds of them when treated with both topical and systemic steroids. Early treatment confers a benefit in terms of the recovery of graft transparency.